FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ale Närvänen

Research Profile

Procedures

Immunoenzyme Techniques

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Disorders

Living Beings

Anatomy

Concepts & Ideas

Molecular Sequence Data

Physiology

Pregnancy

Co-author Network

Publications

TOP 3
Johanna M Mattsson; Ale Närvänen; Ulf-Håkan Stenman; Hannu Koistinen
Peptides binding to prostate-specific antigen enhance its antiangiogenic activity.
Tuulia Huhtala; Anu Jalanko; Martti Kaasalainen; Raili Riikonen; Jussi Rytkönen; Jarno Salonen; Ale Närvänen
Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis.
Tuulia Huhtala; Pirjo Laakkonen; Hanna Sallinen; Seppo Ylä-Herttuala; Ale Närvänen
In vivo SPECT/CT imaging of human orthotopic ovarian carcinoma xenografts with 111In-labeled monoclonal antibodies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ale Närvänen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Johanna M Mattsson; Ale Närvänen; Ulf-Håkan Stenman; Hannu Koistinen
Peptides binding to prostate-specific antigen enhance its antiangiogenic activity.
The Prostate 2012;72(14):1588-94.
2012: Tuulia Huhtala; Anu Jalanko; Martti Kaasalainen; Raili Riikonen; Jussi Rytkönen; Jarno Salonen; Ale Närvänen
Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis.
Journal of drug delivery 2012;2012():626417.
2010: Tuulia Huhtala; Pirjo Laakkonen; Hanna Sallinen; Seppo Ylä-Herttuala; Ale Närvänen
In vivo SPECT/CT imaging of human orthotopic ovarian carcinoma xenografts with 111In-labeled monoclonal antibodies.
Nuclear medicine and biology 2010;37(8):957-64.
2010: Tuure Kinnunen; Anssi Nieminen; William W Kwok; Ale Närvänen; Marja Rytkönen-Nissinen; Soili Saarelainen; Antti Taivainen; Tuomas Virtanen
Allergen-specific naïve and memory CD4+ T cells exhibit functional and phenotypic differences between individuals with or without allergy.
European journal of immunology 2010;40(9):2460-9.
2010: Miikka Pakkala; Janne Weisell; Can Hekim; Jouko Vepsäläinen; Erik A A Wallen; Ulf-Håkan Stenman; Hannu Koistinen; Ale Närvänen
Mimetics of the disulfide bridge between the N- and C-terminal cysteines of the KLK3-stimulating peptide B-2.
Amino acids 2010;39(1):233-42.
2010: Can Hekim; Tero Riipi; Janne Weisell; Ale Närvänen; Riitta Koistinen; Ulf-Håkan Stenman; Hannu Koistinen
Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides.
Biological chemistry 2010;391(4):475-9.
2010: Ping Wu; Janne Weisell; Miikka Pakkala; Mikael Peräkylä; Lei Zhu; Riitta Koistinen; Erkki Koivunen; Ulf-Håkan Stenman; Ale Närvänen; Hannu Koistinen
Identification of novel peptide inhibitors for human trypsins.
Biological chemistry 2010;391(2-3):283-93.
2007: Anu K Immonen; Antti Taivainen; Ale Närvänen; Tuure Kinnunen; Soili A Saarelainen; Marja A Rytkönen-Nissinen; Tuomas I Virtanen
Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.
Immunology 2007;120(1):38-46.
2002: Barbro Krevers; Ale Närvänen; Birgitta Oberg
Patient evaluation of the care and rehabilitation process in geriatric hospital care.
Disability and rehabilitation 2002;24(9):482-91.
1997: Ale Närvänen; M Puolakkainen; W Hao; K Kino; J Suni
Detection of Antibodies to Chlamydia trachomatis With Peptide-Based Species-Specific Enzyme Immunoassay.
Infectious diseases in obstetrics and gynecology 1997;5(5):349-54.
1996: Marjaleena Koskiniemi; P Ammälä; Ale Närvänen; P Saikku; M Söderlund; P Koskela; P Laurila; Antti Vaheri
Stillbirths and maternal antibodies to Chlamydia trachomatis. A new EIA test for serology.
Acta obstetricia et gynecologica Scandinavica 1996;75(7):657-61.
1995: Olli Vapalahti; Hannimari Kallio-Kokko; Ale Närvänen; Ilkka Julkunen; Ake Lundkvist; Alexander Plyusnin; H Lehväslaiho; Markus Brummer-Korvenkontio; Antti Vaheri; Hilkka Lankinen
Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response.
Journal of medical virology 1995;46(4):293-303.
1993: Merja Roivainen; L Piirainen; T Rysä; Ale Närvänen; Tapani Hovi
An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution.
Virology 1993;195(2):762-5.
1993: P Salo; Ale Närvänen; Maija Leinonen
Mapping of immunoreactive sites of pneumococcal pneumolysin by use of synthetic peptides.
Infection and immunity 1993;61(7):2822-6.
1992: Jorma Ilonen; H Seppänen; Ale Närvänen; M Korkolainen; Aimo A Salmi
Recognition of synthetic peptides with sequences of rubella virus E1 polypeptide by antibodies and T lymphocytes.
Viral immunology 1992;5(3):221-8.
1991: Oliviero Varnier; Ale Närvänen; M Korkolainen; Flavia B Lillo; S Kontio; J Elm; Jukka Suni; A Vaheri; M L Huhtala
Synthetic peptides in HIV antibody screening and typing.
Annals of the New York Academy of Sciences 1991;626():502-15.
1991: Merja Roivainen; Ale Närvänen; M Korkolainen; M L Huhtala; Tapani Hovi
Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique.
Virology 1991;180(1):99-107.
1989: Päivi Liesi; Ale Närvänen; J Soos; H Sariola; Georges Snounou
Identification of a neurite outgrowth-promoting domain of laminin using synthetic peptides.
FEBS letters 1989;244(1):141-8.
1988: Ale Närvänen; M Korkolainen; Jukka Suni; J Korpela; S Kontio; P Partanen; A Vaheri; M L Huhtala
Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection.
Journal of medical virology 1988;26(2):111-8.
1988: Ale Närvänen; M Korkolainen; S Kontio; Jukka Suni; S Turtianen; P Partanen; J Soos; A Vaheri; M L Huhtala
Highly immunoreactive antigenic site in a hydrophobic domain of HIV-1 gp41 which remains undetectable with conventional immunochemical methods.
AIDS (London, England) 1988;2(2):119-23.
1987: O Närvänen; Ale Närvänen; Veli-Matti Wasenius; P Partanen; Ismo Virtanen
A monoclonal antibody against a synthetic peptide reveals common structures among spectrins and alpha-actinin.
FEBS letters 1987;224(1):156-60.
1987: M L Huhtala; Markku Seppala; Ale Närvänen; P Palomäki; M Julkunen; H Bohn
Amino acid sequence homology between human placental protein 14 and beta-lactoglobulins from various species.
Endocrinology 1987;120(6):2620-2.
1985: T Wahlström; Jukka Suni; P Nieminen; Ale Närvänen; T Lehtonen; A Vaheri
Renal cell adenocarcinoma and retrovirus p30-related antigen excreted to urine.
Laboratory investigation; a journal of technical methods and pathology 1985;53(4):464-9.
1985: Ale Närvänen
Purification, from cultured human choriocarcinoma cells, of a 75000-Mr protein reacting with antibodies to a synthetic peptide based on a cloned human endogenous provirus nucleotide sequence.
The Biochemical journal 1985;231(1):53-7.
1985: T Wahlström; Ale Närvänen; Jukka Suni; R Pakkanen; T Lehtonen; E Saksela; A Vaheri; T Copeland; M Cohen; S Oroszlan
Mr 75,000 protein, a tumor marker in renal adenocarcinoma, reacting with antibodies to a synthetic peptide based on a cloned human endogenous retroviral nucleotide sequence.
International journal of cancer. Journal international du cancer 1985;36(3):379-82.
1984: T Wahlström; P Nieminen; Ale Närvänen; Jukka Suni; P Lehtovirta; E Saksela; A Vaheri
Monoclonal antibody defining a human syncytiotrophoblastic polypeptide immunologically related to mammalian retrovirus structural protein p30.
Placenta 1984;5(6):465-73.
1984: Jukka Suni; Ale Närvänen; T Wahlström; M Aho; R Pakkanen; A Vaheri; T Copeland; M Cohen; S Oroszlan
Human placental syncytiotrophoblastic Mr 75,000 polypeptide defined by antibodies to a synthetic peptide based on a cloned human endogenous retroviral DNA sequence.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(19):6197-201.
1984: Jukka Suni; Ale Närvänen; T Wahlström; P Lehtovirta; A Vaheri
Monoclonal antibody to human T-cell leukemia virus p19 defines polypeptide antigen in human choriocarcinoma cells and syncytiotrophoblasts of first-trimester placentas.
International journal of cancer. Journal international du cancer 1984;33(3):293-8.